borderline significantP = 0.049
marginally significantP = 0.06
When the analysis was restricted to mothers who reported ≥80% adherence during the pregnancy period ( n = 316 in the non-LNS group and n = 134 in the LNS group), we observed a marginally significantly higher SBP in the non-LNS group than in the LNS group (99.6 ± 0.6 compared with 97.7 ± 0.9 mm Hg; P = 0.06), a borderline significant difference in SBP z score (0.70 ± 0.05 compared with 0.51 ± 0.08; P = 0.049), and a marginally significant difference in the prevalence of high BP (34.9% compared with 26.2%; P = 0.08).